Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dextromethorphan Hydrobromide 1.5 MG/ML Oral Solution [Pediacare Long Acting Reformulated Feb 2010]

Known as: Pediacare Long Acting Reformulated Feb 2010 1.5 MG/ML Oral Solution, PediaCare Children's Long Acting Cough 7.5 MG in 5 mL Oral Solution, Reformulated Feb 2010, DEXTROMETHORPHAN HYDROBROMIDE 7.5 mg in 5 mL ORAL LIQUID [PediaCare LongActing Cough] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Introduction Adolescents who seek care in the emergency department (ED) are a cohort at increased risk of unintended pregnancy… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
http://dx.doi.org/10.1016/j.annepidem.2015.10.007 1047-2797/ 2016 Elsevier Inc. All rights reserved. Results from observational… Expand
  • table 1
Is this relevant?
2014
2014
A major barrier to understanding the mechanism of nitric oxide reductases (NORs) is the lack of a selective probe of NO binding… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND QVA149 is an inhaled fixed-dose combination therapy under development for the treatment of chronic obstructive… Expand
Is this relevant?
Review
2011
Review
2011
Hypertension is prevalent in an estimated 29% to 80% of patients treated with peritoneal dialysis (PD). Cardiovascular disease… Expand
  • figure 1
  • figure 2
Is this relevant?
2007
2007
In their recent article on the effects of anti–tumor necrosis factor (TNF)in asthma, Erin and colleagues report that infliximab… Expand
Is this relevant?
2003
2003
PRINCIPLES Current asthma management employing inhaled corticosteroids (ICS) and longacting b2-agonists (LABA) aims to rapidly… Expand
  • table 1
  • table 2
  • figure 3
  • figure 1
  • figure 4
Is this relevant?